| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Gilead Sciences is currently navigating significant challenges in drug development, particularly highlighted by the setbacks with its breast cancer medication Trodelvy, which has not met essential study objectives. However, the company is achieving notable success with Livdelzi®, which demonstrates sustained efficacy in treating primary biliary cholangitis, enhancing patient health outcomes. The dual nature of these developments illustrates the complexities within the company's product and service development trajectory. As Gilead continues to innovate, balancing these successes with ongoing challenges will be crucial for future growth. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.3 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.3 on 2025-11-12. The forces of Valuation Sentiment (-1), and Sentiment towards Fundamentals (-0.9) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| GILD | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | 0%(0%) | 0 | 0% | -0.3 | -0.9 | -1 | |||||||
| 2025-11-11 | 0%(0%) | 0 | 0% | -0.3 | -0.9 | -1 | |||||||
| 2025-11-10 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-11-09 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-11-08 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-11-06 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-11-05 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-11-04 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-12 17:11:53 The regulatory environment may play a role in stock movements, though it is less highlighted in the current articles. |
| 2025-11-12 17:11:53 The increase in shares bought by investors indicates a form of capital injection, which is generally viewed positively. |
| 2025-11-12 17:11:53 The activity from institutional investors shows confidence in the leadership and strategic direction of Gilead Sciences. |
| 2025-11-12 17:11:53 The mention of Allworth Financial LP boosting its position in Gilead signifies interest from investment firms, which is a positive indicator for the stock. |
| 2025-11-12 17:11:53 The articles reflect a positive sentiment around the stock performance of Gilead Sciences, Inc., indicating steady gains. |